Peter Siegel

28PUBLICATIONS
157CO-AUTHORS
Predictive and prognostic markersProteomics and intermolecular interactions (excl. medical proteomics)Haematological tumoursMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 01, 2026
Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC.

|Jun 04, 2026
Co-enrichment of proteins in extracellular vesicles.

|May 05, 2026
Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics.

|Apr 15, 2026
PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

|Jan 03, 2026
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial.

April A N Rose, Jennifer Maxwell, Emmanuelle Rousselle

|Jul 11, 2025
Complex I inhibition combined with TLR activation in the breast tumor microenvironment educates cytotoxic neutrophils.

John Heath, Ryuhjin Ahn, Valerie Sabourin

Pageof 5

Frequent Collaborators

7 joint publications

Matthew G Annis

6 joint publications

Sébastien Tabariès

6 joint publications

Morag Park

3 joint publications

Julie St-Pierre